Bioinformatics and network-based approaches for determining pathways, signature molecules, and drug substances connected to genetic basis of schizophrenia etiology
- 23 March 2022
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1785, 147889
- https://doi.org/10.1016/j.brainres.2022.147889
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisThe Lancet, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Transcriptome Sequencing Revealed Significant Alteration of Cortical Promoter Usage and Splicing in SchizophreniaPLOS ONE, 2012
- Genome-Wide Association Study of Treatment Refractory Schizophrenia in Han ChinesePLOS ONE, 2012
- MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain functionProceedings of the National Academy of Sciences of the United States of America, 2012
- Genome-wide expression profiling of schizophrenia using a large combined cohortMolecular Psychiatry, 2012
- Schizophrenia Genetics: Where Next?Schizophrenia Bulletin, 2011
- Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and functionHippocampus, 2010
- A Genome-Wide Investigation of SNPs and CNVs in SchizophreniaPLoS Genetics, 2009
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003